{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:09:00Z","timestamp":1793506140317,"version":"4.5.0"},"reference-count":134,"publisher":"Elsevier","isbn-type":[{"value":"9780443224201","type":"print"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/bs.pmbts.2024.07.018","type":"book-chapter","created":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T19:28:21Z","timestamp":1723922901000},"page":"21-46","source":"Crossref","is-referenced-by-count":4,"title":["Recent progress in CRISPR\/Cas9 system for eye disorders"],"prefix":"10.1016","author":[{"given":"D.A. Ayush","family":"Gowda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girish","family":"Birappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sripriya","family":"Rajkumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Bindu","family":"Ajaykumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavana","family":"Srikanth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sammy L.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijai","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparna","family":"Jayachandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junwon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh","family":"Ramakrishna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/bs.pmbts.2024.07.018_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2016.09.001","article-title":"In vivo genome editing as a potential treatment strategy for inherited retinal dystrophies","volume":"56","author":"Yanik","year":"2017","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib2","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1111\/bph.14024","article-title":"Principles of pharmacology in the eye","volume":"174","author":"Awwad","year":"2017","journal-title":"Br J Pharmacol"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib3","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nrd1106","article-title":"Ophthalmic drug discovery","volume":"2","author":"Clark","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib4","doi-asserted-by":"crossref","first-page":"lqab050","DOI":"10.1093\/nargab\/lqab050","article-title":"EyeDiseases: an integrated resource for dedicating to genetic variants, gene expression and epigenetic factors","volume":"3","author":"Yuan","year":"2021","journal-title":"of human eye diseases NAR Genom Bioinform"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib5","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/ajmg.c.31824","article-title":"The genetic landscape of inherited eye disorders in 74 consecutive families from the United Arab Emirates","volume":"184","author":"M\u00e9j\u00e9case","year":"2020","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib6","article-title":"Global causes of blindness and distance vision impairment","volume":"5","author":"Flaxman","year":"2017","journal-title":"Lancet Glob Health"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib7","doi-asserted-by":"crossref","first-page":"101029","DOI":"10.1016\/j.preteyeres.2021.101029","article-title":"Inherited retinal diseases: Linking genes, disease-causing variants, and relevant therapeutic modalities","volume":"89","author":"Schneider","year":"2022","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib8","first-page":"132","article-title":"CRISPR\/Cas therapeutic strategies for autosomal dominant disorders","author":"Caruso","year":"2022","journal-title":"J Clin Invest"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib9","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2210104119","article-title":"Precision genome editing in the eye","volume":"119","author":"Suh","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.visres.2023.108192","article-title":"Genome editing, a superior therapy for inherited retinal diseases","volume":"206","author":"Yan","year":"2023","journal-title":"Vis Res"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib11","first-page":"220","article-title":"Eye on genome editing","author":"Du","year":"2023","journal-title":"J Exp Med"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911482","article-title":"CRISPR\/Cas9-A promising therapeutic tool to cure blindness: Current scenario and future prospects","volume":"23","author":"Ahmad","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib13","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s40266-015-0300-y","article-title":"Treatment of exudative age-related macular degeneration: Focus on aflibercept, drugs aging","volume":"32","author":"Garc\u00eda-Layana","year":"2015","journal-title":"Drugs Aging"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib14","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/S0161-6420(85)33872-1","article-title":"Complications of surgery in glaucoma. Suprachoroidal expulsive hemorrhage in glaucoma patients undergoing intraocular surgery","volume":"92","author":"Cantor","year":"1985","journal-title":"Ophthalmology"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib15","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0887-8994(90)90010-X","article-title":"Partial cytochrome b deficiency and generalized dystonia","volume":"6","author":"Nigro","year":"1990","journal-title":"Pediatr Neurol"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib16","first-page":"21","article-title":"CRISPR-Cas9 DNA base-editing and prime-editing","author":"Kantor","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1074\/jbc.R700039200","article-title":"The mechanism of human nonhomologous DNA end joining","volume":"283","author":"Lieber","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib18","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev.biochem.052308.093131","article-title":"The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway","volume":"79","author":"Lieber","year":"2010","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib19","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0027-5107(01)00115-4","article-title":"Homologous recombinational repair of DNA ensures mammalian chromosome stability","volume":"477","author":"Thompson","year":"2001","journal-title":"Mutat Res"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib20","first-page":"21","article-title":"Methods favoring homology-directed repair choice in response to CRISPR\/Cas9 induced-double strand breaks","author":"Yang","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib21","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nbt.2808","article-title":"Improving CRISPR-Cas nuclease specificity using truncated guide RNAs","volume":"32","author":"Fu","year":"2014","journal-title":"Nat Biotechnol"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib22","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nm.3793","article-title":"Therapeutic genome editing: prospects and challenges","volume":"21","author":"Cox","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib23","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1093\/nar\/gkr1112","article-title":"A novel zinc-finger nuclease platform with a sequence-specific cleavage module","volume":"40","author":"Schierling","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib24","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.omtn.2019.02.027","article-title":"Genome-editing technologies: Concept, pros, and cons of various genome-editing techniques and bioethical concerns for clinical application","volume":"16","author":"Khan","year":"2019","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib25","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/nbt.3659","article-title":"Applications of CRISPR technologies in research and beyond","volume":"34","author":"Barrangou","year":"2016","journal-title":"Nat Biotechnol"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib26","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/s41551-021-00760-7","article-title":"CRISPR-based diagnostics","volume":"5","author":"Kaminski","year":"2021","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib27","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nrd.2016.238","article-title":"Cornerstones of CRISPR-Cas in drug discovery and therapy","volume":"16","author":"Fellmann","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib28","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2147\/nano.2007.2.1.65","article-title":"Age-related macular degeneration: a target for nanotechnology derived medicines","volume":"2","author":"Birch","year":"2007","journal-title":"Int J Nanomed"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib29","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1167\/iovs.10-6163","article-title":"Mitochondrial DNA damage and repair in RPE associated with aging and age-related macular degeneration","volume":"52","author":"Lin","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib30","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.survophthal.2008.10.004","article-title":"Fundus autofluorescence and progression of age-related macular degeneration","volume":"54","author":"Schmitz-Valckenberg","year":"2009","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib31","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/S0140-6736(12)60282-7","article-title":"Age-related macular degeneration","volume":"379","author":"Lim","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib32","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1056\/NEJMra0801537","article-title":"Age-related macular degeneration","volume":"358","author":"Jager","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib33","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.37765\/ajmc.2020.43435","article-title":"Wet age-related macular degeneration: treatment advances to reduce the injection burden","volume":"26","author":"Baumal","year":"2020","journal-title":"Am J Manag Care"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib34","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ajo.2007.09.008","article-title":"The epidemiology of retinal reticular drusen","volume":"145","author":"Klein","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib35","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1016\/j.ophtha.2009.12.012","article-title":"Progression of geographic atrophy and genotype in age-related macular degeneration","volume":"117","author":"Klein","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib36","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1136\/bjophthalmol-2016-308422","article-title":"Drusen volume development over time and its relevance to the course of age-related macular degeneration","volume":"101","author":"Schlanitz","year":"2017","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib37","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1167\/iovs.11-9338","article-title":"Is drusen area really so important? An assessment of risk of conversion to neovascular AMD based on computerized measurements of drusen","volume":"53","author":"Friberg","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib38","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1001\/jamaophthalmol.2020.0824","article-title":"Association of 2-Year progression along the AREDS AMD scale and development of late age-related macular degeneration or loss of visual acuity","volume":"138","author":"Vitale","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib39","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/nri3459","article-title":"Immunology of age-related macular degeneration","volume":"13","author":"Ambati","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib40","first-page":"105","article-title":"Vascular endothelial growth factors and their inhibitors in ocular neovascular disorders","volume":"4","author":"Homayouni","year":"2009","journal-title":"J Ophthalmic Vis Res"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib41","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.cell.2019.01.021","article-title":"VEGF in signaling and disease: Beyond discovery and development","volume":"176","author":"Apte","year":"2019","journal-title":"Cell"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib42","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.clinph.2019.11.029","article-title":"An update on retinal prostheses","volume":"131","author":"Ayton","year":"2020","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib43","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1101\/gr.219089.116","article-title":"Genome surgery using Cas9 ribonucleoproteins for the treatment of age-related macular degeneration","volume":"27","author":"Kim","year":"2017","journal-title":"Genome Res"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib44","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41551-020-00656-y","article-title":"Lentiviral delivery of co-packaged Cas9 mRNA and a Vegfa-targeting guide RNA prevents wet age-related macular degeneration in mice","volume":"5","author":"Ling","year":"2021","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib45","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.omtn.2022.04.015","article-title":"CRISPR-based VEGF suppression using paired guide RNAs for treatment of choroidal neovascularization","volume":"28","author":"Chung","year":"2022","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib46","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejpb.2015.04.029","article-title":"The aqueous humor outflow pathways in glaucoma: A unifying concept of disease mechanisms and causative treatment","volume":"95","author":"Braunger","year":"2015","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib47","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1093\/hmg\/ddi068","article-title":"Identification of a novel adult-onset primary open-angle glaucoma (POAG) gene on 5q22.1","volume":"14","author":"Monemi","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib48","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jns.2006.02.009","article-title":"High frequency of open-angle glaucoma in Japanese patients with Alzheimer\u2019s disease","volume":"246","author":"Tamura","year":"2006","journal-title":"J Neurol Sci"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib49","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/IJG.0000000000000627","article-title":"Targeting transforming growth factor-\u03b2 signaling in primary open-angle glaucoma","volume":"26","author":"Wang","year":"2017","journal-title":"J Glaucoma"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib50","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1167\/iovs.07-0835","article-title":"Tissue transglutaminase expression and activity in normal and glaucomatous human trabecular meshwork cells and tissues","volume":"49","author":"Tovar-Vidales","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib51","doi-asserted-by":"crossref","first-page":"5240","DOI":"10.1167\/iovs.11-7287","article-title":"Transforming growth factor-beta induces extracellular matrix protein cross-linking lysyl oxidase (LOX) genes in human trabecular meshwork cells","volume":"52","author":"Sethi","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib52","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1167\/iovs.16-19672","article-title":"TGF\u03b22 induces the formation of cross-linked actin networks (CLANs) in human trabecular meshwork cells through the smad and non-smad dependent pathways","volume":"58","author":"Montecchi-Palmer","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib53","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0039-6257(02)00353-3","article-title":"Myocilin glaucoma","volume":"47","author":"Fingert","year":"2002","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib54","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1172\/JCI58183","article-title":"Reduction of ER stress via a chemical chaperone prevents disease phenotypes in a mouse model of primary open angle glaucoma","volume":"121","author":"Zode","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib55","doi-asserted-by":"crossref","first-page":"5594","DOI":"10.1038\/s41467-020-19352-1","article-title":"ATF4 leads to glaucoma by promoting protein synthesis and ER client protein load","volume":"11","author":"Kasetti","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib56","first-page":"6","article-title":"Autophagy stimulation reduces ocular hypertension in a murine glaucoma model via autophagic degradation of mutant myocilin","author":"Kasetti","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib57","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.ymthe.2019.12.012","article-title":"Gene therapy for glaucoma by ciliary body aquaporin 1 disruption using CRISPR-Cas9","volume":"28","author":"Wu","year":"2020","journal-title":"Mol Ther"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib58","doi-asserted-by":"crossref","first-page":"11199","DOI":"10.1073\/pnas.1706193114","article-title":"CRISPR-Cas9-based treatment of myocilin-associated glaucoma","volume":"114","author":"Jain","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib59","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1167\/iovs.62.12.7","article-title":"Using CRISPR interference as a therapeutic approach to treat TGF\u03b22-induced ocular hypertension and glaucoma","volume":"62","author":"Rayana","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib60","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/APO.0000000000000227","article-title":"Retinitis Pigmentosa: Progress and Perspective","volume":"5","author":"Zhang","year":"2016","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib61","doi-asserted-by":"crossref","first-page":"368rv366","DOI":"10.1126\/scitranslmed.aaf2838","article-title":"Emerging therapies for inherited retinal degeneration","volume":"8","author":"Scholl","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib62","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1750-1172-1-40","article-title":"Retinitis pigmentosa","volume":"1","author":"Hamel","year":"2006","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib63","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/IIO.0000000000000256","article-title":"Retinitis pigmentosa: Review of current treatment","volume":"59","author":"Wang","year":"2019","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib64","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax1738","article-title":"BAP1 regulates epigenetic switch from pluripotency to differentiation in developmental lineages giving rise to BAP1-mutant cancers","volume":"5","author":"Kuznetsov","year":"2019","journal-title":"Sci Adv"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib65","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.preteyeres.2018.03.005","article-title":"Non-syndromic retinitis pigmentosa","volume":"66","author":"Verbakel","year":"2018","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib66","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nbt.3081","article-title":"Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo","volume":"33","author":"Zuris","year":"2015","journal-title":"Nat Biotechnol"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib67","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1073\/pnas.1520244113","article-title":"Efficient delivery of genome-editing proteins using bioreducible lipid nanoparticles","volume":"113","author":"Wang","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib68","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/hmg\/ddx438","article-title":"Cas9\/sgRNA selective targeting of the P23H Rhodopsin mutant allele for treating retinitis pigmentosa by intravitreal AAV9.PHP.B-based delivery","volume":"27","author":"Giannelli","year":"2018","journal-title":"Hum Mol Genet"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib69","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ddtec.2018.05.001","article-title":"CRISPR\/Cas9 genome surgery for retinal diseases","volume":"28","author":"Xu","year":"2018","journal-title":"Drug Discov Today Technol"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib70","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14040824","article-title":"AAV-CRISPR\/Cas9 gene editing preserves long-term vision in the P23H rat model of autosomal dominant retinitis pigmentosa","volume":"14","author":"Shahin","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib71","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/mt.2015.220","article-title":"In vivo CRISPR\/Cas9 gene editing corrects retinal dystrophy in the S334ter-3 rat model of autosomal dominant retinitis pigmentosa","volume":"24","author":"Bakondi","year":"2016","journal-title":"Mol Ther"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib72","doi-asserted-by":"crossref","DOI":"10.1111\/aos.12486","article-title":"Prevalence of Rhodopsin mutations in autosomal dominant Retinitis Pigmentosa in Spain: clinical and analytical review in 200 families","volume":"93","author":"Fernandez-San Jose","year":"2015","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib73","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ajhg.2021.01.006","article-title":"Allele-specific editing ameliorates dominant retinitis pigmentosa in a transgenic mouse model","volume":"108","author":"Patrizi","year":"2021","journal-title":"Am J Hum Genet"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib74","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1073\/pnas.93.2.557","article-title":"Vision: from photon to perception","volume":"93","author":"Stryer","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib75","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1167\/iovs.18-25556","article-title":"Development of a Pde6b gene knockout rat model for studies of degenerative retinal diseases","volume":"60","author":"Yeo","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib76","doi-asserted-by":"crossref","first-page":"eaav3335","DOI":"10.1126\/sciadv.aav3335","article-title":"In vivo genome editing rescues photoreceptor degeneration via a Cas9\/RecA-mediated homology-directed repair pathway","volume":"5","author":"Cai","year":"2019","journal-title":"Sci Adv"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib77","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1038\/mt.2016.107","article-title":"CRISPR repair reveals causative mutation in a preclinical model of retinitis pigmentosa","volume":"24","author":"Wu","year":"2016","journal-title":"Mol Ther"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib78","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s12098-017-2394-1","article-title":"Leber\u2019s congenital amaurosis and gene therapy","volume":"85","author":"Takkar","year":"2018","journal-title":"Indian J Pediatr"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib79","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jaapos.2009.10.004","article-title":"Leber congenital amaurosis: clinical correlations with genotypes, gene therapy trials update, and future directions","volume":"13","author":"Chung","year":"2009","journal-title":"J AAPOS"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib80","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1136\/bjophthalmol-2016-309975","article-title":"Leber congenital amaurosis\/early-onset severe retinal dystrophy: clinical features, molecular genetics and therapeutic interventions","volume":"101","author":"Kumaran","year":"2017","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib81","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/humu.9485","article-title":"Spectrum of NPHP6\/CEP290 mutations in Leber congenital amaurosis and delineation of the associated phenotype","volume":"28","author":"Perrault","year":"2007","journal-title":"Hum Mutat"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib82","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ymthe.2016.12.006","article-title":"CRISPR\/Cas9-mediated genome editing as a therapeutic Approach for leber congenital amaurosis 10","volume":"25","author":"Ruan","year":"2017","journal-title":"Mol Ther"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib83","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41591-018-0327-9","article-title":"Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10","volume":"25","author":"Maeder","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib84","doi-asserted-by":"crossref","first-page":"eaax1210","DOI":"10.1126\/sciadv.aax1210","article-title":"CRISPR-Cas9-mediated therapeutic editing of Rpe65 ameliorates the disease phenotypes in a mouse model of Leber congenital amaurosis","volume":"5","author":"Jo","year":"2019","journal-title":"Sci Adv"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib85","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41551-020-00632-6","article-title":"Restoration of visual function in adult mice with an inherited retinal disease via adenine base editing","volume":"5","author":"Suh","year":"2021","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib86","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1038\/s41467-022-29490-3","article-title":"In vivo base editing rescues cone photoreceptors in a mouse model of early-onset inherited retinal degeneration","volume":"13","author":"Choi","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib87","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(17)31868-8","article-title":"Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial","volume":"390","author":"Russell","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib88","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.ophtha.2019.06.017","article-title":"Efficacy, safety, and durability of voretigene neparvovec-rzyl in RPE65 mutation-associated inherited retinal dystrophy: Results of phase 1 and 3 trials","volume":"126","author":"Maguire","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib89","doi-asserted-by":"crossref","first-page":"8366","DOI":"10.1038\/srep08366","article-title":"CRISPR-engineered mosaicism rapidly reveals that loss of Kcnj13 function in mice mimics human disease phenotypes","volume":"5","author":"Zhong","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib90","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1167\/iovs.61.5.38","article-title":"Gene deletion impairs cell alignment and phagocytosis in retinal pigment epithelium derived from human-induced pluripotent stem cells","volume":"61","author":"Kanzaki","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib91","doi-asserted-by":"crossref","first-page":"15014","DOI":"10.1038\/nrdp.2015.14","article-title":"Cataract","volume":"1","author":"Lam","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib92","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.survophthal.2004.02.013","article-title":"Molecular genetic basis of inherited cataract and associated phenotypes","volume":"49","author":"Reddy","year":"2004","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib93","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1076\/opep.10.2.67.13894","article-title":"Birth prevalence of visually significant infantile cataract in a defined U.S. population","volume":"10","author":"Holmes","year":"2003","journal-title":"Ophthalmic Epidemiol"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib94","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.semcdb.2007.10.003","article-title":"Congenital cataracts and their molecular genetics","volume":"19","author":"Hejtmancik","year":"2008","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib95","first-page":"2007","article-title":"Cat-Map: putting cataract on the map","volume":"16","author":"Shiels","year":"2010","journal-title":"Mol Vis"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib96","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.exer.2016.06.011","article-title":"Mutations and mechanisms in congenital and age-related cataracts","volume":"156","author":"Shiels","year":"2017","journal-title":"Exp Eye Res"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib97","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ymeth.2020.12.004","article-title":"Rapid and efficient cataract gene evaluation in F0 zebrafish using CRISPR-Cas9 ribonucleoprotein complexes","volume":"194","author":"Zhao","year":"2021","journal-title":"Methods"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib98","doi-asserted-by":"crossref","first-page":"22024","DOI":"10.1038\/srep22024","article-title":"CRISPR\/Cas9-mediated GJA8 knockout in rabbits recapitulates human congenital cataracts","volume":"6","author":"Yuan","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib99","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.stem.2013.10.016","article-title":"Correction of a genetic disease in mouse via use of CRISPR-Cas9","volume":"13","author":"Wu","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib100","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nature12111","article-title":"The zebrafish reference genome sequence and its relationship to the human genome","volume":"496","author":"Howe","year":"2013","journal-title":"Nature"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib101","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/02713688909013899","article-title":"Evidence for the presence of phosphoinositide cycle and its involvement in cellular signal transduction in the rabbit lens","volume":"8","author":"Vivekanandan","year":"1989","journal-title":"Curr Eye Res"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib102","first-page":"1063","article-title":"Lumbar pain","volume":"73","author":"Brodin","year":"1976","journal-title":"Lakartidningen"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib103","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00439-022-02518-w","article-title":"A tapt1 knock-out zebrafish line with aberrant lens development and impaired vision models human early-onset cataract","volume":"142","author":"Jarayseh","year":"2023","journal-title":"Hum Genet"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib104","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s00417-015-3019-x","article-title":"A novel Cx50 (GJA8) p.H277Y mutation associated with autosomal dominant congenital cataract identified with targeted next-generation sequencing","volume":"253","author":"Chen","year":"2015","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib105","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1242\/dev.129.1.167","article-title":"Disruption of Gja8 (alpha8 connexin) in mice leads to microphthalmia associated with retardation of lens growth and lens fiber maturation","volume":"129","author":"Rong","year":"2002","journal-title":"Development"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib106","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00232-007-9033-0","article-title":"Connexins in lens development and cataractogenesis","volume":"218","author":"Gong","year":"2007","journal-title":"J Membr Biol"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib107","article-title":"A novel GJA8 mutation is associated with autosomal dominant lamellar pulverulent cataract: further evidence for gap junction dysfunction in human cataract","volume":"43","author":"Arora","year":"2006","journal-title":"J Med Genet"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib108","first-page":"190","article-title":"Novel mutations in GJA8 associated with autosomal dominant congenital cataract and microcornea","volume":"12","author":"Devi","year":"2006","journal-title":"Mol Vis"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib109","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1034\/j.1399-0004.2001.600614.x","article-title":"Mutation in the connexin 50 gene (GJA8) in a Russian family with zonular pulverulent cataract","volume":"60","author":"Polyakov","year":"2001","journal-title":"Clin Genet"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib110","doi-asserted-by":"crossref","DOI":"10.1136\/jmg.40.11.e124","article-title":"A novel GJA8 mutation in an Iranian family with progressive autosomal dominant congenital nuclear cataract","volume":"40","author":"Willoughby","year":"2003","journal-title":"J Med Genet"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib111","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/(SICI)1520-6408(1999)24:1\/2<27::AID-DVG4>3.0.CO;2-7","article-title":"Genetic factors influence cataract formation in alpha 3 connexin knockout mice","volume":"24","author":"Gong","year":"1999","journal-title":"Dev Genet"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib112","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1016\/S0006-3495(03)74646-3","article-title":"Changes in the refractive index of the stroma and its extrafibrillar matrix when the cornea swells","volume":"85","author":"Meek","year":"2003","journal-title":"Biophys J"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib113","doi-asserted-by":"crossref","first-page":"190","DOI":"10.4103\/ijo.IJO_646_17","article-title":"Anatomy of cornea and ocular surface","volume":"66","author":"Sridhar","year":"2018","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib114","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/ng0397-247","article-title":"Kerato-epithelin mutations in four 5q31-linked corneal dystrophies","volume":"15","author":"Munier","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib115","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41587-020-00781-8","article-title":"Targeting herpes simplex virus with CRISPR-Cas9 cures herpetic stromal keratitis in mice","volume":"39","author":"Yin","year":"2021","journal-title":"Nat Biotechnol"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib116","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1016\/j.ymthe.2023.08.021","article-title":"In vivo CRISPR gene editing in patients with herpetic stromal keratitis","volume":"31","author":"Wei","year":"2023","journal-title":"Mol Ther"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib117","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1167\/iovs.04-0937","article-title":"Inheritance of a novel COL8A2 mutation defines a distinct early-onset subtype of fuchs corneal dystrophy","volume":"46","author":"Gottsch","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib118","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1093\/hmg\/10.21.2415","article-title":"Missense mutations in COL8A2, the gene encoding the alpha2 chain of type VIII collagen, cause two forms of corneal endothelial dystrophy","volume":"10","author":"Biswas","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib119","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.55637","article-title":"Start codon disruption with CRISPR\/Cas9 prevents murine Fuchs\u2019 endothelial corneal dystrophy","volume":"10","author":"Uehara","year":"2021","journal-title":"Elife"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib120","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jtos.2013.12.002","article-title":"Clinical and genetic aspects of the TGFBI-associated corneal dystrophies","volume":"12","author":"Lakshminarayanan","year":"2014","journal-title":"Ocul Surf"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib121","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000027395","article-title":"Granular-lattice (Avellino) corneal dystrophy","volume":"213","author":"Akiya","year":"1999","journal-title":"Ophthalmologica"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib122","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0161-6420(88)33226-4","article-title":"Clinically atypical granular corneal dystrophy with pathologic features of lattice-like amyloid deposits. A study of these families","volume":"95","author":"Folberg","year":"1988","journal-title":"Ophthalmology"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib123","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/S0161-6420(99)90441-4","article-title":"Recurrence of corneal dystrophy after excimer laser phototherapeutic keratectomy","volume":"106","author":"Dinh","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib124","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/S0161-6420(94)31096-7","article-title":"Granular corneal dystrophy. Visual results and pattern of recurrence after lamellar or penetrating keratoplasty","volume":"101","author":"Lyons","year":"1994","journal-title":"Ophthalmology"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib125","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1038\/s41598-020-58876-w","article-title":"Generation of mouse model of TGFBI-R124C corneal dystrophy using CRISPR\/Cas9-mediated homology-directed repair","volume":"10","author":"Kitamoto","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib126","doi-asserted-by":"crossref","first-page":"16713","DOI":"10.1038\/s41598-017-16308-2","article-title":"Repair of the TGFBI gene in human corneal keratocytes derived from a granular corneal dystrophy patient via CRISPR\/Cas9-induced homology-directed repair","volume":"7","author":"Taketani","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib127","first-page":"11","article-title":"Genetic variants affecting anti-VEGF drug response in polypoidal choroidal vasculopathy patients: A systematic review and meta-analysis","author":"D\u00edaz-Villamar\u00edn","year":"2020","journal-title":"Genes (Basel)"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib128","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.bbadis.2014.11.020","article-title":"retinal degeneration and associated abnormalities","volume":"1852","author":"Mathur","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib129","doi-asserted-by":"crossref","first-page":"417217","DOI":"10.1155\/2011\/417217","article-title":"An update on the genetics of usher syndrome","volume":"2011","author":"Mill\u00e1n","year":"2011","journal-title":"J Ophthalmol"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib130","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/S0140-6736(06)69740-7","article-title":"Retinitis pigmentosa","volume":"368","author":"Hartong","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib131","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114817","article-title":"Early disruption of photoreceptor cell architecture and loss of vision in a humanized pig model of usher syndromes","volume":"14","author":"Grotz","year":"2022","journal-title":"EMBO Mol Med"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib132","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41572-022-00339-9","article-title":"Uveal melanoma","volume":"8","author":"Jager","year":"2022","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib133","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/bjc.2014.417","article-title":"Lack of BAP1 protein expression in uveal melanoma is associated with increased metastatic risk and has utility in routine prognostic testing","volume":"111","author":"Kalirai","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/bs.pmbts.2024.07.018_bib134","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.3389\/fphar.2019.01456","article-title":"Knockdown of PTGS2 by CRISPR\/CAS9 system designates a new potential gene target for melanoma treatment","volume":"10","author":"Ercolano","year":"2019","journal-title":"Front Pharmacol"}],"container-title":["Progress in Molecular Biology and Translational Science","CRISPR-Cas-Based Genome Editing for Treating Human Diseases-Part B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117324001674?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117324001674?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T05:37:55Z","timestamp":1740634675000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877117324001674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9780443224201"],"references-count":134,"URL":"https:\/\/doi.org\/10.1016\/bs.pmbts.2024.07.018","relation":{},"ISSN":["1877-1173"],"issn-type":[{"value":"1877-1173","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}